The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Aug 2017 07:00

RNS Number : 8090M
Grupo Clarin S.A.
02 August 2017
 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.

 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes should in block capital letters.

 

1. Name of the issuer

 

GRUPO CLARÍN S.A.

....................................

 

2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii):

 

....................................

 

3. Name of person discharging managerial responsibilities/director

 

ALEJANDRO ALBERTO URRICELQUI (MANAGER)

SEBASTIAN BARDENGO (MANAGER and ALTERNATE DIRECTOR)

 

....................................

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

....................................

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

3 ABOVE

....................................

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

- URRICELQUI - CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINE PESO PER SHARE IN THE FORM OF GLOBAL DEPOSITARY SHARES

 

 - BARDENGO - CLASS B COMMON SHARES OF THE COMPANY, WITH NOMINAL VALUE OF ONE (1) ARGENTINE PESO PER SHARE

 

....................................

 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

N/A

....................................

 

8. State the nature of the transaction

 

- URRICELQUI - ACQUISITION OF CLASS B COMMON SHARES IN THE FORM OF GLOBAL DEPOSITARY SHARES

 

-BARDENGO - ACQUISITION OF CLASS B COMMON SHARES

 

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

 

ALEJANDRO A. URRICELQUI Number of shares: 31,000 GDSs, representing 2 Class B Common Shares each

 

SEBASTIAN BARDENGO Number of shares: 1,460 Class B Common Shares

....................................

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

ALEJANDRO A. URRICELQUI Percentage: 0.0333% of CLASS B COMMON SHARES

 

 

SEBASTIAN BARDENGO Percentage: 0.0008% of CLASS B COMMON SHARES

....................................

 

11. Number of shares, debentures or financial instruments relating to shares disposed

N/A

....................................

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

....................................

 

 

13. Price per share or value of transaction

 

 

ALEJANDRO A. URRICELQUI 31,000 GDS at US$ 28.38 per GDS

 

SEBASTIAN BARDENGO: 1,460 shares at AR$ 239.12 per share

 

 

14. Date and place of transaction

 

 

ALEJANDRO A. URRICELQUI: 31,000 GDS on 21, 24 and 26 July 2017, LONDON

 

SEBASTIAN BARDENGO: 1,460 SHARES on 20 July 2017, Buenos Aires

....................................

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

ALEJANDRO A. URRICELQUI:

173,158 COMMON SHARES (0.0602% OF OUTSTANDING CAPITAL STOCK)

 

SEBASTIAN BARDENGO:

6,460 COMMON SHARES (0.0022% OF OUTSTANDING CAPITAL STOCK)

 

 

....................................

 

16. Date issuer informed of transaction

 

....................................

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17. Date of grant

....................................

18. Period during which or date on which it can be exercised

....................................

19. Total amount paid (if any) for grant of the option

....................................

20. Description of shares or debentures involved (class and number)

....................................

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

....................................

22. Total number of shares or debentures over which options held following notification

....................................

 

23. Any additional information

 

N/A

....................................

 

24. Name of contact and telephone number for queries

 

IN BUENOS AIRES:

AGUSTIN MEDINA MANSON/PATRICIO GENTILE

GRUPO CLARÍN

EMAIL: INVESTORS@GRUPOCLARIN.COM

 

IN LONDON:

ALEX MONEY

JASFORD IR

TEL: +44 20 3289 5300

EMAIL: ALEXM@JASFORD.COM 

 

IN NEW YORK:

MELANIE CARPENTER

I-ADVIZE CORPORATE COMMUNICATIONS

TEL: +1 212 406 3692

EMAIL: CLARIN@I-ADVIZE.COM

....................................

Name and signature of duly authorised officer of issuer responsible for making notification

 

AGUSTIN MEDINA MANSON, Responsible for Market Relations, Grupo Clarín S.A.

....................................

Date of notification

August 1st, 2017

....................................

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSSFMFFWSEFA
Date   Source Headline
11th Apr 20227:00 amRNSGCLA Responds to Shareholder Information Request
7th Apr 20224:54 pmRNSGCLA Responds to Shareholder Information Request
4th Apr 20227:00 amRNSGCLA Shareholders' Meeting to be Held Remotely
4th Apr 20227:00 amRNSGCLA responds to shareholder information request
1st Apr 20221:40 pmRNSGCLA subsidiary sells Auto Sports S.A.
16th Mar 20227:03 amRNSAppointment of alternate market relations officer
11th Mar 202212:16 pmRNSFull Year and Last Quarter 2021 Results
11th Mar 20228:39 amRNSGrupo Clarin Calls Annual Shareholders' Meeting
11th Feb 20227:00 amRNSSubsidiary Inversora de Eventos sells Auto Sports
16th Dec 20214:42 pmRNSSecond Price Monitoring Extn
16th Dec 20214:36 pmRNSPrice Monitoring Extension
2nd Dec 20219:24 amRNSCourt renders decision
11th Nov 20217:41 amRNSNine months and Third Quarter 2021 Results
23rd Sep 20217:41 amRNSCourt Dismisses Company Petition
12th Aug 20218:12 amRNSFirst Half and Second Quarter 2021 Results
23rd Jul 20214:33 pmRNSSale of Bariloche TV
20th Jul 20213:12 pmRNSDecision in Pol Ka Dispute
14th Jul 20214:40 pmRNSSecond Price Monitoring Extn
14th Jul 20214:35 pmRNSPrice Monitoring Extension
9th Jul 20214:35 pmRNSPrice Monitoring Extension
24th Jun 20214:41 pmRNSSecond Price Monitoring Extn
24th Jun 20214:35 pmRNSPrice Monitoring Extension
18th May 20217:59 amRNSShareholder sues subsidiary Pol Ka Producciones SA
13th May 20212:07 pmRNSGrupo Clarín Announces First Quarter 2021 Results
4th May 20217:06 amRNSGCLA Informs Positions in Audit Committee
4th May 20217:00 amRNSGrupo Clarin discloses list of company authorities
4th May 20217:00 amRNSOrdinary and Extraordinary Shareholders' Meeting
30th Apr 20212:03 pmRNSCourt rejects appeal
23rd Apr 20217:13 amRNSShareholders' Meeting to be held Remotely
13th Apr 20213:33 pmRNSResponse to Information Request
24th Mar 20218:21 amRNSOfficer Responsible for Market Relations
23rd Mar 20217:42 amRNSGrupo Clarín Calls Annual Shareholders’ Meeting
12th Mar 20217:00 amRNS4Q2020 and FY2020 Results
9th Mar 20213:12 pmRNSNotice of Results
7th Dec 20207:00 amRNSNine Month and Third Quarter 2020 Results
27th Nov 20208:15 amRNSNotice of Third Quarter Results (3Q 2020)
8th Sep 20207:59 amRNSFirst Half and Second Quarter 2020 Results
1st Sep 20205:32 pmRNSNotice of Results
9th Jun 20207:37 amRNS1st Quarter Results
4th Jun 20208:17 amRNSConference call and webcast of Q1 2020 Results
2nd Jun 20207:35 amRNSAnnual Financial Report
4th May 20208:48 amRNSAGM Statement
17th Apr 20205:10 pmRNSResponse to shareholder information request
19th Mar 20202:22 pmRNSGrupo Clarín Calls Annual Shareholders’ Meeting
10th Mar 20208:35 amRNSFourth Quarter and Full Year 2019 Results
6th Mar 20207:00 amRNSNotice of Results
3rd Dec 201911:48 amRNSCourt Nullifies 2010 Allocation of Earnings
12th Nov 20197:21 amRNSThird Quarter and Nine-Month 2019 Results
7th Nov 20193:51 pmRNSNotice of Results
24th Oct 201910:33 amRNSAcquisition of Real Property from Subsidiary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.